Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. (LSTA) — Form 8-K: Current report
About this filing
Lisata Therapeutics, Inc. (LSTA) filed an 8-K on Nov 9, 2026 reporting an executive or director change or pay arrangement (Item 5.02), shareholder vote results (Item 5.07) and other events (Item 8.01), with exhibits (Item 9.01).
Key facts
- Item 5.02 · Executive or director change or pay arrangement
- Item 5.07 · Shareholder vote results
- Item 8.01 · Other events
- Item 9.01 · Financial statements and exhibits
More LSTA filings
- ARS
Filed Oct 19, 2026
- DEF 14A
Filed Oct 19, 2026
- 3
Filed Oct 15, 2026
- 8-K
Filed Oct 14, 2026
- PRE 14A
Filed Oct 7, 2026
- D
Filed Oct 2, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.